FDA released guidance on Circumstances that Constitute Delay [Regulatives / Guidelines]

posted by drgunasakaran1  – 2014-11-03 18:18 (4251 d 05:02 ago) – Posting: # 13827
Views: 4,046

Dear all,

FDA released Guidance for Industry, Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug Inspection.

http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM360484.pdf
—
Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
134 visitors (0 registered, 134 guests [including 36 identified bots]).
Forum time: 00:21 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5